Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tadeja Urbanic Purkart
Observed names:
T Urbanic Purkart,
T. Urbanic Purkart,
Tadeja Urbanic-Purkart
Institutions:
Medical University of Graz,
Center For Biomarker Research In Medicine
Observed institutions:
University of Graz,
Medical University of Graz,
Graz University Hospital,
Center For Biomarker Research In Medicine
ORCID:
0000-0001-5101-868X
Observed ORCID:
0000-0001-5101-868X
OpenAlex ID:
A5035458339
Effect of High-Dose Vitamin D 3 on Hospital Length of Stay in Critically Ill Patients With Vitamin D Deficiency: The VITdAL-ICU Randomized Clinical Trial
2014
·
Karin Amrein
, Christian Schnedl
, et al.
·
JAMA
·
553
Vitamin D status and its association with season, hospital and sepsis mortality in critical illness
2014
·
Karin Amrein
, Paul Zajic
, et al.
·
Critical Care
·
169
PDF
The effect of high-dose cholecalciferol on bioavailable vitamin D levels in critically ill patients: a post hoc analysis of the VITdAL-ICU trial
2017
·
Gennaro Martucci
, Fabio Tuzzolino
, et al.
·
Intensive Care Medicine
·
30
MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy
2022
·
Johanna Heugenhauser
, Malik Galijasevic
, et al.
·
Cancers
·
16
PDF
Instrumental activities of daily living in neuro-oncology: International validation of the EORTC IADL-BN32 questionnaire
2024
·
Q. Oort
, J.C. Reijneveld
, et al.
·
European Journal of Cancer
·
14
PDF
Personalized targeted glioblastoma therapies by ex vivo drug screening: Study protocol of the Advanced brain Tumor TheRApy Clinical Trial (ATTRACT)
2025
·
Anna Sophie Berghoff
, Maximilian J Mair
, et al.
·
Neuro-Oncology Advances
·
13
PDF
Vitamin D and Hyperkinetic Movement Disorders: A Systematic Review
2020
·
Carl N. Homann
, Gerd Ivanic
, et al.
·
Tremor and Other Hyperkinetic Movements
·
13
Patient-Reported Outcomes, Neurocognitive Functioning, and Oncologic Results of Pencil Beam Scanning Proton Beam Therapy for CNS WHO G2 and G3 IDH1-Mutant Diffuse Adult Glioma: A Single Institution Experience
2025
·
Maciej J. Pelak
, Allan Hummer
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
3
PDF
Personalized targeted glioblastoma therapies by ex vivo drug screening: Advanced brain tumor therapy clinical trial (ATTRACT).
2025
·
Anna Sophie Berghoff
, Matthias Preusser
, et al.
·
Journal of Clinical Oncology
·
3
Vanishing midbrain mass lesion - A germinoma?
2019
·
Tadeja Urbanic Purkart
, Thomas Seifert-Held
, et al.
·
Journal of the Neurological Sciences
·
3
Towards more Diversity in Neuro-oncology Leadership—the DivINe Initiative
2023
·
Sylvia C Kurz
, Anja Stammberger
, et al.
·
Neuro-Oncology
·
2
PDF
Radiomics for risk stratification in brain metastases: potential in melanoma brain metastases
2026
·
Johanna Heugenhauser
, Sabrina Herbst
, et al.
·
Clinical & Experimental Metastasis
·
1
PDF
P13.06.a Radiomic Features for Risk-stratification in Patients With Brain Metastases
2023
·
J Heugenhauser
, S Herbst
, et al.
·
Neuro-Oncology
·
1
PDF
Does increase of symptoms mean progression?
2022
·
Christine Marosi
, Tadeja Urbanic Purkart
·
Neuro-Oncology
·
1
PDF
TIP-01 Personalized targeted glioblastoma therapies by ex vivo drug screening: Advanced brain Tumor TheRApy Clinical Trial (ATTRACT)
2026
·
Anna S Berghoff
, Maximilian J Mair
, et al.
·
Neuro-Oncology
TIP-04 Personalized targeted glioblastoma therapies by ex vivo drug screening: Advanced brain Tumor TheRApy Clinical Trial In patients scheduled for shOrt course radiatioN (ATTRACTION)
2026
·
Anna S Berghoff
, Maximilian J Mair
, et al.
·
Neuro-Oncology
IDH-Mutant Diffuse Glioma: From Metabolic Origins to Targeted Therapy
2026
·
Tadeja Urbanic-Purkart
·
Journal of Clinical Medicine
Metabolomic and drug profiling of patient-derived glioblastoma models uncovers targetable vulnerabilities in IDH wild-type tumors
2026
·
Kariem Mahdy Ali
, Fernanda Ferreira da Silva Souza Monedeiro
, et al.
·
Acta Neuropathologica Communications
P12.04.a Personalized Targeted Glioblastoma Therapies by Ex Vivo Drug Screening: Advanced Brain Tumor Therapy Clinical Trial (attract)
2025
·
A S Berghoff
, M J Mair
, et al.
·
Neuro-Oncology
PDF
P01.10.b Factors Impacting the Quality of Patient-derived Cells (pdcs) for Drug Screening in Patients With Newly Diagnosed Glioblastoma
2025
·
B Kiesel
, K Syboeck
, et al.
·
Neuro-Oncology
PDF
P01.36.b Modeling Spinal Dissemination in Glioblastoma Using Post-mortem and Ex Vivo Approaches
2025
·
T Urbanic Purkart
, M Leoni
, et al.
·
Neuro-Oncology
PDF
P01.20.b Convergent Evolution of Tumor Progression in Glioblastoma Patients
2025
·
S Stanzer
, M Kramer-Drauberg
, et al.
·
Neuro-Oncology
PDF
Die molekularen Gesichter des Glioblastoms
2025
·
Tadeja Urbanic Purkart
·
psychopraxis neuropraxis
Neurologische Nebenwirkungen von CAR-T-Zell-Therapien
2025
·
Tadeja Urbanic Purkart
, Michael Khalil
·
psychopraxis neuropraxis
PDF
P18.05.b Association of Cellular Drug Responses and Metabolic Profiles in Adult Type Diffuse Gliomas
2024
·
S Stanzer
, J Bandres-Meriz
, et al.
·
Neuro-Oncology
PDF
Show more works
View as search
Works count:
37
Citation count:
835
H-index:
8
I10-index:
8
Year
Topic
Type